Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kolon TissueGene doses first subject in Phase III invossa trial

Xray of hips showing narrowing of joint space in osteoarthritis. Credit: Wellcome Photo Library. Wellcome Images.



  • invossa

Go Top